Altered Telomeres in Tumors with ATRX and DAXX Mutations

Chromosome tips seem to be maintained by an unusual mechanism in tumors that have mutations in chromatin remodeling genes. The proteins encoded by ATRX and DAXX participate in chromatin remodeling at telomeres and other genomic sites. Because inactivating mutations of these genes are common in human pancreatic neuroendocrine tumors (PanNETs), we examined the telomere status of these tumors. We found that 61% of PanNETs displayed abnormal telomeres that are characteristic of a telomerase-independent telomere maintenance mechanism termed ALT (alternative lengthening of telomeres). All of the PanNETs exhibiting these abnormal telomeres had ATRX or DAXX mutations or loss of nuclear ATRX or DAXX protein. ATRX mutations also correlate with abnormal telomeres in tumors of the central nervous system. These data suggest that an alternative telomere maintenance function may operate in human tumors with alterations in the ATRX or DAXX genes.

[1]  Michael A. Choti,et al.  DAXX/ATRX, MEN1, and mTOR Pathway Genes Are Frequently Altered in Pancreatic Neuroendocrine Tumors , 2011, Science.

[2]  Steven J. M. Jones,et al.  ATR-X Syndrome Protein Targets Tandem Repeats and Influences Allele-Specific Expression in a Size-Dependent Manner , 2010, Cell.

[3]  R. Reddel,et al.  Assaying and investigating Alternative Lengthening of Telomeres activity in human cells and cancers , 2010, FEBS letters.

[4]  C. Allis,et al.  Daxx is an H3.3-specific histone chaperone and cooperates with ATRX in replication-independent chromatin assembly at telomeres , 2010, Proceedings of the National Academy of Sciences.

[5]  S. Rafii,et al.  Distinct Factors Control Histone Variant H3.3 Localization at Specific Genomic Regions , 2010, Cell.

[6]  R. Hannan,et al.  ATRX interacts with H3.3 in maintaining telomere structural integrity in pluripotent embryonic stem cells. , 2010, Genome research.

[7]  C. Allis,et al.  HIRA and Daxx constitute two independent histone H3.3-containing predeposition complexes. , 2010, Cold Spring Harbor symposia on quantitative biology.

[8]  Angela Tam,et al.  Histone H3.3 incorporation provides a unique and functionally essential telomeric chromatin in embryonic stem cells. , 2008, Genome research.

[9]  C. Azzalin,et al.  Telomeric Repeat–Containing RNA and RNA Surveillance Factors at Mammalian Chromosome Ends , 2007, Science.

[10]  M. Cerone,et al.  A human cell line that maintains telomeres in the absence of telomerase and of key markers of ALT , 2005, Oncogene.

[11]  R. Reddel,et al.  Telomerase-independent telomere length maintenance in the absence of alternative lengthening of telomeres-associated promyelocytic leukemia bodies. , 2005, Cancer research.

[12]  L. Guarente,et al.  A novel telomere structure in a human alternative lengthening of telomeres cell line. , 2005, Cancer research.

[13]  Dihua Yu,et al.  A robust assay for alternative lengthening of telomeres in tumors shows the significance of alternative lengthening of telomeres in sarcomas and astrocytomas. , 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.

[14]  E. Montgomery,et al.  Telomere lengths of translocation-associated and nontranslocation-associated sarcomas differ dramatically. , 2004, The American journal of pathology.

[15]  J. Qin,et al.  The ATRX syndrome protein forms a chromatin-remodeling complex with Daxx and localizes in promyelocytic leukemia nuclear bodies , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[16]  M. Ladanyi,et al.  Absence of a telomere maintenance mechanism as a favorable prognostic factor in patients with osteosarcoma. , 2003, Cancer research.

[17]  J. Royds,et al.  Alternative lengthening of telomeres and survival in patients with glioblastoma multiforme , 2003, The Lancet.

[18]  L. Guillou,et al.  Telomerase activity and hTERT mRNA expression can be heterogeneous and does not correlate with telomere length in soft tissue sarcomas , 2002, International journal of cancer.

[19]  W. Gage,et al.  Telomere length assessment in human archival tissues: combined telomere fluorescence in situ hybridization and immunostaining. , 2002, The American journal of pathology.

[20]  R. Reddel,et al.  Telomerase-negative immortalized human cells contain a novel type of promyelocytic leukemia (PML) body. , 1999, Cancer research.

[21]  M. Egholm,et al.  Single base discrimination of CENP-B repeats on mouse and human Chromosomes with PNA-FISH , 1999, Mammalian Genome.

[22]  R. Reddel,et al.  Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines , 1997, Nature Medicine.

[23]  B. Gallie,et al.  Development of retinoblastoma in the absence of telomerase activity. , 1996, Journal of the National Cancer Institute.